Cargando…
Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
This study aimed to investigate the cytotoxicity and anticancer activity of (±)-kusunokinin derivatives ((±)-TTPG-A and (±)-TTPG-B). The cytotoxicity effect was performed on human cancer cells, including breast cancer, cholangiocarcinoma, colon and ovarian cancer-cells, compared with normal cells, u...
Autores principales: | Rattanaburee, Thidarath, Sermmai, Patpanat, Tangthana-umrung, Kornthip, Thongpanchang, Tienthong, Graidist, Potchanapond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735782/ https://www.ncbi.nlm.nih.gov/pubmed/36500383 http://dx.doi.org/10.3390/molecules27238291 |
Ejemplares similares
-
Trans-(−)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?
por: Rattanaburee, Thidarath, et al.
Publicado: (2021) -
Trans-(±)-Kusunokinin Binding to AKR1B1 Inhibits Oxidative Stress and Proteins Involved in Migration in Aggressive Breast Cancer
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2022) -
Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells
por: Mad-Adam, Nadeeya, et al.
Publicado: (2022) -
Trans-(±)-TTPG-B Attenuates Cell Cycle Progression and Inhibits Cell Proliferation on Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2023) -
(−)-Kusunokinin as a Potential Aldose Reductase
Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2020)